Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
Medication-Assisted Treatment (MAT) provides an opportunity to address opioid addiction among justice-involved individuals, an often difficult to reach population. This potential has been increasingly recognized by agencies, policymakers and pharmaceutical companies. The result has been a marked increase in the number of drug courts, prisons and agencies in which MAT, notably with long-acting injectable medications, is offered. While this is a positive development, ensuring that vulnerable individuals are in a position voluntarily participation within the complex criminal justice environment is necessary. The unequal authority and agency inherent in the nature of these environments should be recognized. Therefore, rigorous protections, mirroring the goals of the consent processes required for medical or sociobehavorial research, should be employed when MAT is offered to protect individual autonomy.
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
Creators
Jordan M Hyatt - Drexel University
Philipp P Lobmaier - Norwegian Centre for Addiction Research, University of Oslo, Kirkeveien 166, building 49, Oslo, 0450, Norway.
Publication Details
Health & justice, v 8(1), pp 7-7
Publisher
Springer BMC
Resource Type
Journal article
Language
English
Academic Unit
Criminology and Justice Studies
Web of Science ID
WOS:000705321100001
Scopus ID
2-s2.0-85081901048
Other Identifier
991019169649204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: